Silent infarcts in young children with sickle cell disease.
about
Interventions for preventing silent cerebral infarcts in people with sickle cell diseaseInterventions for preventing silent cerebral infarcts in people with sickle cell diseaseBlood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseSilent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemiaStroke in patients with sickle cell disease.Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.Magnetic resonance imaging in pediatric sickle cell anemia.Development and feasibility of a home-based education model for families of children with sickle cell diseaseReproducibility of detecting silent cerebral infarcts in pediatric sickle cell anemia.Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.Genome-wide meta-analysis of systolic blood pressure in children with sickle cell diseaseUpper airway genioglossal activity in children with sickle cell disease.Parent education and biologic factors influence on cognition in sickle cell anemiaDeterminants of academic performance in children with sickle cell anaemia.Ischemic stroke in infants and children: practical management in emergency.Thrombospondin-1 and L-selectin are associated with silent cerebral infarct in children with sickle cell anaemia.Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.Genetic modifiers of sickle cell diseaseCognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI Study.Prospects for primary stroke prevention in children with sickle cell anaemiaBlood transfusion for preventing primary and secondary stroke in people with sickle cell disease.Barriers in transition from pediatrics to adult medicine in sickle cell anemia.Interventions for preventing silent cerebral infarcts in people with sickle cell disease.A novel, clinically relevant use of a piglet model to study the effects of anesthetics on the developing brainDevelopmental function in toddlers with sickle cell anemia.Acute silent cerebral ischemic events in children with sickle cell anemia.Extent of silent cerebral infarcts in adult sickle-cell disease patients on magnetic resonance imaging: is there a correlation with the clinical severity of disease?Patent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature.Maintaining High Level of Care at Satellite Sickle Cell Clinics.The role of neuropsychological evaluation in pediatric sickle cell disease.Cerebral infarction in children with sickle cell disease: a concise overview.Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia.The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease.Sickle Cell Disease and Stroke: Diagnosis and Management.Intelligence quotient in paediatric sickle cell disease: a systematic review and meta-analysis.Quantitative Analysis of Extracranial Arterial Tortuosity in Patients with Sickle Cell Disease.The possible impact of teachers and school nurses on the lives of children living with sickle cell disease.Intravascular hemolysis and the pathophysiology of sickle cell disease.Utility of the Montreal Cognitive Assessment as a Screening Test for Neurocognitive Dysfunction in Adults with Sickle Cell Disease
P2860
Q24186853-6B8AF9D7-359A-4705-9235-60CAB43F6EBDQ24200712-503D4792-C01E-4F4F-99CD-5D9B78AB6BFDQ24202463-49D2A6BA-D0E3-4B8F-A0CD-C3634F7C8955Q27026479-D0C4529A-0A00-4AE9-961F-B8661B66AE3BQ30650303-4A613E57-ACF4-4670-A301-6601DE869BA0Q30757538-DEF8E17B-B5FC-40DD-912D-627EBD40702BQ31116644-2F351E02-B479-42A3-972D-2F472E6B6C32Q31150442-805E18E7-0817-4C8A-AE95-EAB11C858CE5Q33894066-7C37A7D1-9D75-4C11-9E2A-D25808528A3AQ33919537-D1AD7222-09D2-48BA-8C75-A02DC22EA16CQ34330904-8EF509AE-36F4-4C7A-8D5B-D1882BAB9419Q34994543-A896083D-127A-4812-93AA-F92EF588583EQ34997426-B838E3FF-5D60-4009-9FF4-ACCBE37935E0Q35026922-0076DFF2-7C73-4D45-9D68-296466B9506BQ35045846-9C153990-0B5A-4637-82FE-91BFB9E4897AQ35110252-A82D32A2-0941-4F0A-9D2D-8AEE7FB57244Q35339935-521D2E88-706C-44C8-9D85-82C5E229B60CQ35909642-C28CE908-0CA4-4703-9D93-DBD6B6D680B7Q36035471-0D51224B-7557-436D-970B-A6C658DCAAFEQ36047049-5F0E5A28-04DD-43C3-A69B-41BAB55FD246Q36105129-BA77E309-CF22-4A39-A85F-FC84EEEEAF8CQ36251052-BF01E23D-2C13-4B14-8AC0-669A435A0EFEQ36286827-419CD51A-D23B-432F-89FE-8300A456FD64Q36370980-C12F9C26-5F0D-4B88-A77A-80F18760502EQ36456244-BDCE6CE6-6958-46EA-9D70-765FE31D42E1Q36568784-1C94D347-23A3-4051-BF9D-A66601629A9FQ36914931-FE544980-AA30-4F99-80E2-683B58EAACDFQ37034611-ACD2898E-6590-46C3-9C46-1D2948493C57Q37061928-BAFFF746-76E4-44D0-91D3-2CA511D1B646Q37607927-D8A718B6-FBC1-4C57-8335-B1EA47BBEEA5Q37874511-384AB626-5E5B-463A-AE76-6B310FEA2BECQ37941865-E39AD4D6-E45C-492E-A936-267B2AC54F96Q38089946-00C9C7BC-2A0F-41AF-A58F-C8674566AC13Q38176054-449FA322-E1D9-48B7-B79E-E83218C1A41DQ38732049-DACC7779-90C0-45B5-A434-57B67FC13334Q38796302-1E7FB696-933D-4B0F-9D51-A9731F0598B3Q39044394-AB4B4E80-3085-40C6-AF3B-54E27F06D35FQ39141870-D94852F8-93B7-4DF7-A5E3-E19287D9D5B9Q39156028-56DF2243-4445-4CCD-AF90-5CB8A19BB85DQ39419775-3365CF79-778B-4478-BA73-EA7F1E42BBDB
P2860
Silent infarcts in young children with sickle cell disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Silent infarcts in young children with sickle cell disease.
@en
Silent infarcts in young children with sickle cell disease.
@nl
type
label
Silent infarcts in young children with sickle cell disease.
@en
Silent infarcts in young children with sickle cell disease.
@nl
prefLabel
Silent infarcts in young children with sickle cell disease.
@en
Silent infarcts in young children with sickle cell disease.
@nl
P2093
P2860
P1476
Silent infarcts in young children with sickle cell disease.
@en
P2093
Anne Blackwood-Chirchir
Avrum N Pollock
Janet L Kwiatkowski
Justine Shults
Kim Smith-Whitley
Robert A Zimmerman
Wendy Seto
P2860
P304
P356
10.1111/J.1365-2141.2009.07753.X
P407
P577
2009-06-04T00:00:00Z